Brief: BioSyent pharma international signed exclusive license, supply agreement with European partner for new women's health product
08/11/2016 13:08
Nov 8 (Reuters) - Biosyent Inc RX.V
* BioSyent says unit, BioSyent pharma international signed
exclusive license, supply agreement with European partner for
new women's health product
Source text for Eikon: urn:newsml:reuters.com:*:nMKW4kSV9a
Further company coverage: RX.V
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Biosyent
See all newsCanada's BioSyent Q2 revenue jumps 95% following Oral Health acquisition
Canada's BioSyent Q1 revenue rises helped by Oral Science acquisition
Brief: Biosyent Announces Closing Of The Acquisition Of Oral Science Inc.
Brief: Biosyent To Acquire Oral Science Inc.
Brief: Biosyent Announces Renewal Of Normal Course Issuer Bid